Summary & Overview
HCPCS J0612: Injection, Calcium Gluconate, 10 mg
HCPCS Level II code J0612 designates an injectable dose of calcium gluconate, specified as 10 mg per unit. This drug code identifies parenteral calcium administration used across acute and ambulatory care settings for management of hypocalcemia and other clinical indications requiring calcium replacement. Nationally, accurate coding of injectable medications like J0612 supports billing consistency, inventory controls, and clinical documentation for medication administration.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how J0612 is used in clinical settings, typical sites of service where the injection is administered, and the coding context relevant to billing teams. The publication provides benchmarks and operational notes where available, summarizes common payer considerations, and outlines areas where policy updates or clarifications commonly arise. Data not available in the input will be identified as such, and no clinical recommendations are provided. This piece is intended for revenue cycle, pharmacy, and clinical staff seeking a concise reference to HCPCS Level II code J0612 and its administrative implications.
Billing Code Overview
HCPCS Level II code J0612 represents an injectable formulation of calcium gluconate measured as 10 mg per unit. The code denotes the pharmaceutical product for parenteral administration and is typically used when injectable calcium supplementation or replacement is required.
Service type: Medication administration (injectable calcium)
Typical site of service: Inpatient hospital, outpatient infusion center, emergency department, or physician office
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an emergency department, urgent care center, or infusion clinic with signs of hypocalcemia such as perioral numbness, muscle cramps, tetany, or cardiac arrhythmia. Laboratory testing reveals a markedly low serum ionized calcium or total corrected calcium. The treating clinician orders parenteral calcium replacement. The billed item J0612 (Injection, calcium gluconate, not otherwise specified, 10 mg) is administered intravenously, often diluted and given slowly to reduce risk of cardiac adverse effects. Vital signs and cardiac monitoring are performed during and after administration. Documentation includes indication, serum calcium level, dose administered (number of units of J0612), route, dilution, time, lot number, and patient response. Typical sites of service are hospital inpatient, emergency department, observation unit, and ambulatory infusion or clinic settings for acute symptomatic hypocalcemia or prophylactic correction in select procedures (for example, during blood transfusion management or post-parathyroidectomy monitoring).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no specific modifier applies and billing requires the base HCPCS only. |